TrialNature medicine2019

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial.

Leonie Voorwerk et al.PubMed ↗Publisher ↗

No numbers read from the abstract.